Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 1,480 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Commercially Available Clear all

Conditions: Cochlear Implant
Interventions: LACE, NOOK; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Lung Cancer
Interventions: Ability to order FirstLook™, Continuing Medical Education for Lung Cancer; Diagnostic Test · Other
Lead sponsor: Delfi Diagnostics Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Aurora, Colorado • Jacksonville, Florida • Durham, North Carolina

Conditions: Psychological Stress, Anxiety, Emotional Stress, Autonomic Nervous System Dysfunction, Sleep Disturbance, Insomnia, Behavioral Health, Cognitive Fatigue, Occupational Stress, Financial Stress, Burnout Syndrome, Heart Rate Variability, Neurobehavioral Manifestations
Interventions: Wearable Physiologic Monitoring Platform; Device
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimers Disease
Interventions: Florbetapir F18; Drug
Lead sponsor: Avid Radiopharmaceuticals; Industry
Eligibility: Not listed
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension, Gut Dysbiosis, Overweight , Obesity
Interventions: Synbiotic, Placebo; Dietary Supplement
Lead sponsor: Southern Utah University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Cedar, Utah

Conditions: Lumbar Spine Surgery
Interventions: Group 1 - Lumoptik BrightPoint Epidural Device; Device
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 99 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual Disease, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Interventions: Dasatinib, Imatinib Mesylate, Nilotinib, Ruxolitinib; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Schizophrenia
Interventions: Neuroadaptive cognitive training, Computer games; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 12 Years to 35 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 2
States / cities: Sacramento, California • San Francisco, California

Conditions: Tooth Loss
Interventions: Sinus lift augmentation and dental implant, Aastrom BRCs; Procedure · Biological
Lead sponsor: University of Michigan; Other
Eligibility: 20 Years to 70 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Pain, Nerve
Interventions: Active Treatment, Non-active Treatment; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Aortic Valve Disease, Aortic Stenosis
Interventions: Perceval valve, other stented biological valve; Device
Lead sponsor: Corcym S.r.l; Industry
Eligibility: 18 Years and older
Enrollment: 914 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 5
States / cities: Indianapolis, Indiana • Portland, Maine • Cleveland, Ohio + 2 more

Conditions: Hemorrhage, Pelvic Fracture
Interventions: Pelvic Binder; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 64 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Colorectal Neoplasms, Melanoma, Prostatic Neoplasms, Renal Cell Carcinoma, Neoplasms, Patients Who Have/Have Had Melanoma and Other Tumors
Interventions: CP-675,206 (Tremelimumab); Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2023
U.S. locations: 5
States / cities: Los Angeles, California • Tampa, Florida • Ann Arbor, Michigan + 2 more

Conditions: Intubation, Laryngoscopy
Interventions: GlideScope videolaryngoscope (Verathon, Bothell, Washington 98011), Direct laryngoscopy; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 7,736 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Infection Control
Interventions: Enhanced cleaning of surfaces in ICU rooms, Sham enhanced cleaning of surfaces in ICU rooms; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement
Interventions: Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems, Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems; Device
Lead sponsor: Medtronic Cardiovascular; Industry
Eligibility: 18 Years and older
Enrollment: 1,103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 61
States / cities: La Jolla, California • Los Angeles, California • San Francisco, California + 47 more

Conditions: Subchondral Cysts, Subchondral Bone Edema, Bone Marrow Edema, Insufficiency Fractures, Avascular Necrosis of Hip, Femoroacetabular Impingement, Dysplasia; Hip
Interventions: Subchondroplasty Procedure with AccuFill; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 6
States / cities: Rancho Mirage, California • Gulf Breeze, Florida • Rockford, Illinois + 3 more

Conditions: Obesity
Interventions: Advice on diet, physical activity, and behavior change, Instruction in food portion size, Provision of pre-portioned foods, Advice on healthy eating for weight loss; Behavioral · Other
Lead sponsor: Penn State University; Other
Eligibility: 20 Years to 65 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Glaucoma
Interventions: Bare Contact Lens, Experimental Smart Contact Lens, Commercially available smart contact lens; Device
Lead sponsor: Indiana University; Other
Eligibility: 22 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Heart Failure
Interventions: Movn app, Accelerometer; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 332 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: HIV
Interventions: Active Cognitive Training (ACT), Control (CON); Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Language Impairment
Interventions: Word Learning Intervention; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 5 Years to 8 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Columbus, Ohio • Austin, Texas

Conditions: Knee Injuries, Knee Osteoarthritis
Interventions: Cutaneous Stimulation, Knee Sleeve; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Mitral Regurgitation, Mitral Valve Insufficiency
Interventions: SAPIEN M3 valve and dock; Device
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 786 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2031
U.S. locations: 44
States / cities: Huntsville, Alabama • Phoenix, Arizona • La Jolla, California + 36 more

Search by objective public record fields.

Title: "Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods"

Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer

NeuroFinance Human Stress Trial During Financial and Informational Volatility

The Feasibility of Florbetapir Quantitation

The Effects of a Commercially Available Synbiotic on the Gut Microbiome and Cardiometabolic Health

Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement

Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors

Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia

Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation

Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain

Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

Endotracheal Intubation Using Videolaryngoscopy Versus Conventional Direct Laryngoscopy

Enhanced Room Cleaning in Intensive Care Units to Reduce Gown and Glove Contamination With Multi-drug-resistant Bacteria

SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

SCP Hip Outcomes Study

Portion Size Strategies for Management of Body Weight

Smart Soft Contact Lenses for Monitoring Glaucoma

Home-based Cardiac Rehabilitation in Heart Failure

Improving Memory Performance by Applying Cognitive Training

Determining Optimal Treatment Intensity for Children With Language Impairment

Gait Modification Treatments for Knee Pathology

The ENCIRCLE Trial